Clarivate Plc
Q3 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: −1.04%.
Did CLVT Beat Earnings? Q3 2025 Results
Clarivate delivered a clear beat in Q3 2025, with adjusted diluted EPS of $0.18 topping the $0.16 consensus estimate by 15.09% and revenue of $623.10 million clearing expectations of $570.35 million by 9.25%, even as total sales held nearly flat year-over-year at just +0.1%. The standout driver behind the revenue outperformance was a surge in transactional book sales ahead of a planned June 2026 disposal, which also prompted management to raise its full-year 2025 revenue outlook to $2.42 billion-$2.46 billion from a prior range of $2.28 billion-$2.40 billion. Organic ACV growth accelerated 30 basis points sequentially to 1.6%, renewal rates improved 100 basis points to 93%, and recurring revenue mix expanded to 88% on a year-to-date organic basis, underscoring the company's deliberate pivot toward higher-quality subscription revenue. Despite the top-line strength, Adjusted EBITDA slipped to $252.40 million from $264.40 million a year ago, with margin compressing 200 basis points to 40.5%, pressured by higher incentive compensation and ongoing product investment. With a strategic alternatives review conclusion expected in February 2026, investors are watching closely for signals on the company's longer-term direction.
- Organic subscription revenue growth of 1.2% driven by new sales and price increases
- Organic ACV grew 1.6% YoY, accelerating 30 bps sequentially
- Renewal rate improved to 93%, up 100 bps YoY
- Recurring revenue mix improved 800 bps to 88% organically
- FX benefit from weaker U.S. dollar
- Higher transactional book sales attributed to A&G wind-down products
“The third quarter demonstrated continued improved financial and operational performance, underscoring the effectiveness of our Value Creation Plan and the increased focus, growth and innovation it enables. By accelerating product and AI development, investing in proprietary assets, and collaborating closely with our customers, we are optimizing our business model and supporting improved sales execution, which is driving organic ACV growth.”
Clarivate CEO, on the earnings call
Forward Guidance & Outlook
Clarivate raised its full-year 2025 revenue outlook to $2.42B–$2.45B from the prior range of $2.28B–$2.40B, reflecting higher transactional book sales ahead of the planned June 2026 disposal and a weaker U.S. dollar. All other guidance metrics were reaffirmed: Organic ACV growth of 1.0%–2.0%, recurring organic revenue growth of (1.0)%–1.0%, Adjusted EBITDA of $940M–$1,000M, Adjusted EBITDA margin of 40.5%–42.5%, Adjusted diluted EPS of $0.60–$0.70, and free cash flow of $300M–$380M. The company expects Adjusted EBITDA at the higher end of the range and organic ACV growth acceleration at the upper end. Current indications point to approximately $2,440M in revenue, ~$995M Adjusted EBITDA, ~$340M free cash flow, and ~$0.65 Adjusted diluted EPS. The company plans to complete its strategic alternatives review and disclose at year-end earnings in February 2026.
CLVT YoY Financials
CLVT Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.